ArticleSignal transduction and targeted therapy2025

Neoleukin-2/15-armored CAR-NK cells sustain superior therapeutic efficacy in solid tumors via c-Myc/NRF1 activation.

Jianhua Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.